Drugs Made In America Acquisition (DMAAR) Notes Payables (2024 - 2025)
Drugs Made In America Acquisition (DMAAR) posted Notes Payables of $60898.0 for Q1 2025, down 90.81% on a QoQ basis from $662324.0 in Q4 2024.
Drugs Made In America Acquisition (DMAAR) Notes Payables (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition's Notes Payables history runs 2 years deep, the most recent figure standing at $60898.0 for Q1 2025.
- Quarterly Notes Payables changed N/A year-over-year to $60898.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $60898.0 (changed N/A YoY) and the FY2024 annual result came in at $662324.0, changed N/A from the prior year.
- Notes Payables was $60898.0 for Q1 2025 at Drugs Made In America Acquisition, down from $662324.0 in the prior quarter.
- Across five years, Notes Payables topped out at $662324.0 in Q4 2024 and bottomed at $60898.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 60,898.00 |
| Dec 31, 2024 | 662,324.00 |